This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Nilesh Wagh: Innovator in Cancer Treatment
Introduction
Nilesh Wagh is an accomplished inventor based in the United States, known for his innovative contributions to cancer treatment. His work focuses on targeting cancer cells that overexpress somatostatin receptors, utilizing advanced compositions and methods to enhance therapeutic efficacy.
Latest Patents
Nilesh Wagh holds a notable patent titled "Treatment Of Cancer Cells Overexpressing Somatostatin Receptors Using Ocreotide Derivatives Chelated To Radioisotopes." This patent describes a cancer-targeting composition, kit, and method designed for the treatment of cancer cells that overexpress somatostatin receptors. The composition includes a radioisotope, a chelator, and a targeting moiety. The chelator features a nitrogen ring structure that includes a tetraazacyclododecane, a triazacyclononane, and/or a tetraazabicyclo [6.6.2] hexadecane derivative. The targeting moiety consists of a somatostatin receptor targeting peptide, which includes an octreotide derivative. This innovative approach allows for the targeted elimination of cancer cells.
Career Highlights
Throughout his career, Nilesh Wagh has worked with several prominent companies in the field of medical innovation. He has been associated with Radiomedix Inc. and Orano Med, where he has contributed to the development of cutting-edge cancer therapies. His expertise in the field has positioned him as a key player in advancing cancer treatment methodologies.
Collaborations
Nilesh has collaborated with notable professionals in his field, including Izabela Tworowska and Ebrahim S Delpassand. These collaborations have further enriched his research and development efforts, leading to significant advancements in cancer treatment.
Conclusion
Nilesh Wagh's innovative work in cancer treatment exemplifies the potential of targeted therapies in modern medicine. His contributions continue to pave the way for new approaches in combating cancer, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile